International Brand Licensing Share Discussion Threads

[philjeans] 15/12/2009 08:18

Yes; IDH going very well and a super little business.

But they already have a quote - I imagine the reverse takeover will involve an unquoted business, short of cash to expand.

Time will tell.

[silverfern] 14/12/2009 16:37

well I got in last week - I have been in iDH for a a long time. Chyeck the ticker and you'll see it's done rather well.

[philjeans] 14/12/2009 08:37

Lots more cash to come in here from sale of the Admiral and Muscle brands throughout the world.

Directors (and friends and family) have snapped up all the shares under the recent offer - a very good sign - and IF there's a right's issue, I'll be delighted to get some more.

Already have a big wedge here and now WELL in profit - see my previous comments over the years!

Of course, a reverse T/O may well produce a business with net cash and no debt anyway - plus IBL'S money in the bank - so a right's issue is not a certainty by any means!

A multi bagger in the making here, without doubt.

[silverfern] 10/12/2009 19:43

therefore serious potential to fall, and bad for business f you want to lever in a private company and render its ownership tradable. So expect a rights issue with any announcements. Have your wallet open because you will have to buy into what is being offered.

[philjeans] 10/12/2009 13:41

Very tighlty held; any serious buying will send these skywards.

Serious potential here.

[silverfern] 10/12/2009 12:34

ANyone else new as a result of the new strategy? Shares are buyable at the moment - I guess there will be rights etc when this reverses into a company in the bio-tech industry

[silverfern] 01/12/2009 13:19

Biosignatures Limited - check out the IDH RNS announcement yesterday - lots of synergie there

[philjeans] 27/11/2009 12:51

Yes; very little stock about. Almost all tightly held by directors or long term investors.

Any spare that comes onto the market has been quickly snapped up for months - now we know why!

Going very much higher as the story unfolds.

[sirshagalot] 27/11/2009 12:38

a few buys and its flying

[philjeans] 26/11/2009 16:17

Held up rather well considering it's the worst day on the markets for months!

The story will be worth reading over the coming months.

[robward] 26/11/2009 10:39

Hi Phil
Happy to hold as well, interesting times ahead.

Rob

[philjeans] 26/11/2009 10:38

Placing fully subscribed; all GONE!

[philjeans] 26/11/2009 09:32

Already cash-rich; just raised a further £1m - mostly through directors taking the shares - an excellent sign!

Plus they will be selling the remaining Admiral and Muscle trade marks and brands throughout the world - that will pull in a further big cash pot.

Then a reverse take over of an established micro medical business (already lined up I have no doubt with the new contacts on the board) and away we go!

Holding very firmly.

[robward] 26/11/2009 09:28

Hi Phil
Lol, that would be interesting

Rob

[philjeans] 26/11/2009 08:14

The chart was telling us (me!) there was something brewing.

I can see 50p here as peeps buy in to the story.

[philjeans] 26/11/2009 08:07

International Brand Licensing plc
("IBL" or "the Company")
Board Changes, Proposed New Strategy, Disposal of Existing Business and Placing
Key points
The Board of IBL is pleased to announce:
* New Board appointments with David Evans joining the Board as non-executive
chairman, Julian Baines as CEO and Dr Kevin Wilson as non-executive director.
* Proposed change in the strategy of the Company moving away from the exploitation
of a portfolio of sports and lifestyle brands to building a business within the
in vitro diagnostic devices ("IVD") market place.
* A placing to raise circa GBP1 million by way of the issue of 8,398,300 new
ordinary shares at a price of 12.75p per share and a commitment to dispose of
the existing licensing business.

Proposed New Strategy
The Board has identified the IVD market place as having significant potential
for generating shareholder value and intends to use IBL as a vehicle to build a
group focused on the IVD industry, through acquisition. The recent Board
appointments bring a wealth of experience in this industry, adding to that of
Gordon Hall, and a strong track record of delivering significant returns to the
shareholders of companies in which they have been directors. The Board's
intention is to deliver attractive returns to shareholders within the next 3-5
years.
The target businesses will be within the diagnostics industry, focusing
initially on applications which will benefit most from the migration of routine
diagnostic testing from the clinical laboratory to the point of care. The target
businesses will have a proven product record, significant intellectual property
and manufacturing expertise.
The IVD Market
In the Directors' opinion, there is a substantial opportunity to construct a
business that can take advantage of the significant ageing profile of the
western world population and help in the diagnosis, treatment and care for older
people.
In vitro diagnostic medical devices are used for the examination of specimen
samples taken from the human body in order to diagnose patients. In particular,
IVDs are used in point of care testing and self testing. As more of the routine
diagnostic testing moves from the clinical laboratory to the point of care, the
Board believes that there will be significant future growth in the use and sale
of IVDs.
General Meeting
Under the AIM Rules for Companies, shareholders' approval is required for the
change of strategy and it is proposed to post a circular to shareholders
shortly; seeking such approval at a general meeting. Once approved by
Shareholders the Company will have 12 months to make an acquisition, or
acquisitions, which constitute a reverse acquisition or implement its investing
strategy. The Board anticipates it will make an acquisition which will
constitute a reverse acquisition within this time frame.
Board appointments and changes
The three new Directors bring a wealth of experience in the diagnostics
industry.
David Evans has significant experience and contacts worldwide within the IVD
industry and is currently chairman of Immunodiagnostic Systems Holdings plc and
Epistem Holdings plc and was formerly a director of BBI Holdings plc ("BBI") and
DxS Limited.
Julian Baines was until recently Group CEO of BBI where he undertook a
management buyout in 2000, a flotation on AIM in 2004 and was responsible for
selling the business to IMI Inc in 2007 for circa GBP85 million. Julian has
resigned from his executive role at BBI but will remain on the board as a non
executive director.
Dr Kevin Wilson has been on the board of a number of public and private
businesses and was Senior Independent Director of BBI from its AIM flotation to
its sale in 2007.
Following the new appointments to the Board, Adam Reynolds has become a
non-executive director and Tony Hutchinson has stepped down from the Board. The
Directors would like to thank Tony for all his efforts over the last 7 years in
developing the Admiral brand and assisting in the disposal of trademark
registrations. Tony will, in the short term, continue to assist the Board with
its strategy of disposing of the licensing business and the Board wishes him
well for the future.

[philjeans] 26/11/2009 08:06

WOW!

Massive changes afoot; glad I held!

Looks to be an absolute stormer.

[robward] 29/10/2009 21:38

Hi Phil
I'm a bit gutted as I was going to use my losses on IBL to offset profits elsewhere !!!

Rob

[philjeans] 29/10/2009 17:43

No matter; 12.8% in a day is fine by me, whatever the reason!

[robward] 29/10/2009 17:09

I havn't got L2 I'm afraid.

[philjeans] 29/10/2009 13:10

rob; any trades on PLUS?

What does L2 look like?

[robward] 29/10/2009 12:54

Hi Phil
Christmas come early lol

[philjeans] 29/10/2009 12:43

8% up currently today and no trades quoted.

Action approaching?

Highest for 12 months plus.

[philjeans] 05/10/2009 13:21

No stock so every tiny Buy produces another rise.

Nice.

[robward] 03/10/2009 08:07

Hi Philjeans
It would be nice if they were buying back stock but somehow I doubt it !!!

Rob